Min Min Yang
Chief Executive Officer presso PHARMABLOCK SCIENCES (NANJING), INC.
Patrimonio netto: 226 M $ in data 31/03/2024
Profilo
Fondatore di PharmaBlock Sciences (Nanjing), Inc., Min Min Yang è presidente di questa società. È anche nel consiglio di amministrazione della Shanghai Ark Biopharmaceutical Co.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/07/2023 | 30 980 300 ( 99.23% ) | 169 M $ | 31/03/2024 | |
| 03/07/2023 | 10 326 800 ( 6.13% ) | 56 M $ | 31/03/2024 |
Posizioni attive di Min Min Yang
| Società | Posizione | Inizio |
|---|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Chief Executive Officer | 21/04/2023 |
| GEMPHARMATECH CO., LTD. | Director/Board Member | 19/10/2023 |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Director/Board Member | 01/03/2021 |
Formazione di Min Min Yang
| Auburn University | Doctorate Degree |
| Nanjing University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GEMPHARMATECH CO., LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
| PharmaBlock Sciences (Nanjing), Inc. |
- Borsa valori
- Insiders
- Min Min Yang
